Global Small Animals Respiratory Diseases Treatment Market 2024 by Company, Regions, Type and Application, Forecast to 2030
According to our (Global Info Research) latest study, the global Small Animals Respiratory Diseases Treatment market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.
According to veterinary medical experts, upper respiratory infections– also called canine infectious respiratory disease (CIRD) is mainly caused in spaces occupied or visited by many pets such as boarding houses, groomers, and parks.
Pet medical care is the second largest segment in pet industry. In the UK, annual spending on veterinary and other pet services has risen from £2.6bn in 2015 to £4bn in 2021, a 54% increase in just six years. According to Vetnosis, the value of the global animal health industry will increase by 12% to $38.3 billion in 2021. White Paper on China's Pet Healthy Consumption of JD shows that in 2023, there are 13.09 million pets entering middle age and old age. And pet aging is expected to be seen in the next few years. Changes in the age structure of pets will further bring about the development of the pet medical industry. According to the data of the 2022 China Pet Medical Industry White Paper, from the perspective of market size, the scale of China's pet medical market is about ¥67.5 billion, accounting for about 22.5% of the entire pet industry. From the perspective of hospital operation time, pet hospitals within 5 years accounted for about 73%. About 11% of the pet hospitals have been in operation for more than 10 years. From the perspective of hospital turnover, nearly 40% of the hospitals have increased their annual turnover year-on-year, and the growth rate is mainly within 21%.
The Global Info Research report includes an overview of the development of the Small Animals Respiratory Diseases Treatment industry chain, the market status of Allergic Pneumonitis (Anthelmintics, Non-steroidal Anti-Inflammatory Drugs (NSAIDs)), Canine Influenza (Anthelmintics, Non-steroidal Anti-Inflammatory Drugs (NSAIDs)), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Small Animals Respiratory Diseases Treatment.
Regionally, the report analyzes the Small Animals Respiratory Diseases Treatment markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Small Animals Respiratory Diseases Treatment market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Small Animals Respiratory Diseases Treatment market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Small Animals Respiratory Diseases Treatment industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the revenue generated, and market share of different by Type (e.g., Anthelmintics, Non-steroidal Anti-Inflammatory Drugs (NSAIDs)).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Small Animals Respiratory Diseases Treatment market.
Regional Analysis: The report involves examining the Small Animals Respiratory Diseases Treatment market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Small Animals Respiratory Diseases Treatment market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Small Animals Respiratory Diseases Treatment:
Company Analysis: Report covers individual Small Animals Respiratory Diseases Treatment players, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Small Animals Respiratory Diseases Treatment This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Allergic Pneumonitis, Canine Influenza).
Technology Analysis: Report covers specific technologies relevant to Small Animals Respiratory Diseases Treatment. It assesses the current state, advancements, and potential future developments in Small Animals Respiratory Diseases Treatment areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Small Animals Respiratory Diseases Treatment market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Small Animals Respiratory Diseases Treatment market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Market segment by Type
Anthelmintics
Non-steroidal Anti-Inflammatory Drugs (NSAIDs)
Corticosteroids
Antibiotics
Antihistamines
Phosphodiesterase (PDE) inhibitors
Bronchodilators
Antineoplastic Agents
Market segment by Application
Allergic Pneumonitis
Canine Influenza
Canine Nasal Mites
Lung Nematodes
Neoplasia Of Respiratory System
Pneumonia
Rhinitis And Sinusitis
Tonsilitis
Market segment by players, this report covers
Zoetis, Inc.
Merck Animal Health
Boehringer Ingelheim GmbH
Bayer AG
Ceva Animal Health
Vetoquinol SA
Virbac Ltd.
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Argentina and Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Small Animals Respiratory Diseases Treatment product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Small Animals Respiratory Diseases Treatment, with revenue, gross margin and global market share of Small Animals Respiratory Diseases Treatment from 2019 to 2024.
Chapter 3, the Small Animals Respiratory Diseases Treatment competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2019 to 2030.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and Small Animals Respiratory Diseases Treatment market forecast, by regions, type and application, with consumption value, from 2025 to 2030.
Chapter 11, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Small Animals Respiratory Diseases Treatment.
Chapter 13, to describe Small Animals Respiratory Diseases Treatment research findings and conclusion.